It is worth noting that a recent study reported that the serum sample and 100 tissue samples from 238 colorectal cancer patients showed high levels of LOX-1 compared with those who present low serum levels, high levels of LOX-1 determine a poorer OS and prognosis of patients. This evidence concerns the gene OLR1 and colorectal cancer.